nevirapine has been researched along with Hearing Loss in 1 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
Hearing Loss: A general term for the complete or partial loss of the ability to hear from one or both ears.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakku, D | 1 |
| Nyaiteera, V | 1 |
| Llowet, E | 1 |
| Nanseera, D | 1 |
| Nakalema, G | 1 |
| Westerberg, B | 1 |
| Bajunirwe, F | 1 |
1 other study available for nevirapine and Hearing Loss
| Article | Year |
|---|---|
HIV status and hearing loss among children between 6 and 12 years of age at a large urban health facility in south western Uganda.
Topics: Anti-Retroviral Agents; Audiometry, Pure-Tone; Child; Cross-Sectional Studies; Female; Hearing Loss; | 2017 |